Yangzhi Xu
Overview
Explore the profile of Yangzhi Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang K, Gu C, Yu G, Lin J, Wang Z, Lu Q, et al.
Liver Res
. 2025 Feb;
6(3):167-174.
PMID: 39958198
Background And Aims: Berberine is one of the most promising clinically tested natural alkaloids, and immunotherapy using natural killer (NK) cells is a potentially effective treatment for hepatocellular carcinoma (HCC)....
2.
Ye L, Zhao D, Xu Y, Lin J, Xu J, Wang K, et al.
J Transl Med
. 2021 Mar;
19(1):101.
PMID: 33750416
Background: Non-alcoholic steatohepatitis (NASH) is a key stage in leading development of non-alcoholic simple fatty liver (NAFL) into cirrhosis and even liver cancer. This study aimed at exploring the lncRNAs...
3.
Mai W, Xu Y, Xu J, Zhao D, Ye L, Yu G, et al.
Front Pharmacol
. 2020 Mar;
11:185.
PMID: 32194416
Berberine (BBR), an isoquinoline alkaloid originating from herbal plants, has been deemed beneficial for non-alcoholic fatty liver disease. Increasing evidence has demonstrated that Nod-like receptor family pyrin domain containing 3...
4.
Zhan Q, Xiang L, Zhao X, An S, Zhou Y, Xu Y, et al.
Medicine (Baltimore)
. 2019 Aug;
98(32):e16819.
PMID: 31393413
To investigate effects of bowel preparation, experience level of colonoscopists, and colonoscopy withdrawal time (CWT) on the quality of an individual opportunistic screening colonoscopy, according to adenoma detection rate (ADR).Data...
5.
Chen X, Xu Y, Zhao D, Chen T, Gu C, Yu G, et al.
Front Pharmacol
. 2018 Aug;
9:888.
PMID: 30135656
Instances of obesity and related metabolic abnormalities are increasing across the world. Non-alcoholic fatty liver disease (NAFLD) is a common disorder in obese people and is becoming the leading cause...
6.
Lai H, Huang J, Xu Y, Zhang J, Chen Z, Xi F, et al.
Saudi J Gastroenterol
. 2018 Apr;
24(3):189-195.
PMID: 29652031
Background/aim: Magnetically-controlled capsule endoscopy (MCE) is a potential option for the evaluation of gastric diseases in cases that are unsuited for conventional endoscopy, avoiding discomfort, sedation, and related complications. This...
7.
Zhan Q, Xiang L, Zhao X, An S, Wang Y, Xu Y, et al.
J Gastroenterol Hepatol
. 2015 Jul;
31(1):172-9.
PMID: 26138256
Background And Aim: It is essential to develop a novel evaluation system for the quality of individual colonoscopy and provide guidelines on whether and when to follow up the patient...
8.
Xu Y, Zhang W, Ye S, Han Z, Bai Y, Li A, et al.
Clin Res Hepatol Gastroenterol
. 2014 Oct;
38(6):757-62.
PMID: 25282556
Background And Objective: The reading of capsule endoscopy (CE) is time-consuming. Thus, several time-saving features have been added to the CE software by different CE companies. However, the similar pictures...
9.
Li Y, Han Z, Zhang W, Wang X, Li A, Xu Y, et al.
Am J Gastroenterol
. 2014 Feb;
109(2):293-5.
PMID: 24496428
No abstract available.